Jonah Comstock

JP Morgan Week 2025 – Paul Hastings

Sanofi's Dupixent scores double COPD win in US, China

Explore the latest hires in pharma and biotech, including executive moves at Seaport Therapeutics, Anthos Therapeutics, Pfizer, and Novartis, from April 2024. Stay updated with the industry’s top talent movements.

In this podcast interview with Dr Fred Aslan from Artiva Biosciences, explore the potential of NK cells in cell therapy and how they could revolutionise the field of immunotherapy beyond CAR-T therapies.

What are the pros and cons of synthetic clinical trials? Get insights from podcast guests Web Sun and Tracy Mayne on the latest developments in this cutting-edge field.

Explore innovation, investment, and policies at the US Pharma and Biotech Summit 2024. Join industry leaders, regulators, and investors to discuss trends shaping healthcare.

In this special edition of the pharmaphorum podcast, the tables have turned as Jonah Comstock puts editors Eloise McLennan and Nicole Raleigh in the hot seat to discuss the biggest trends and talking points from last month’s Reuters Pharma Europe 2024 in Barcelona.

The ADHD drug shortage continues - what’s causing the ongoing lack of access to medications like Adderall and Methylphenidate? This blog post explores the factors behind the shortage.

Merino Perugini from Nestlé Health Science sat down for an exclusive interview with Jonah Comstock from Reuters Pharma USA to discuss the company’s latest innovations and successes in the healthcare industry. Get insights into their strategies and future plans.

Stay updated on the latest STEM Healthcare news from Reuters Pharma USA 2024, featuring insights from global account lead at STEM, Serena Goodwin on the impact of AI in healthcare.

It’s 2024 and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another. How did we get here? And how do we get past it? On today’s pharmaphorum podcast, host Jonah Comstock speaks with Iddo Peleg, CEO of Yonalink, about these very questions.

Discover the latest trends in leadership appointments and C-suite hires in the digital and supplier space from March 2024 in our in-depth analysis.

Last week, pharmaphorum editor-in-chief Jonah Comstock travelled to Philadelphia for Reuters Pharma USA. On today’s podcast, he chats with guest host and Deep Dive editor Eloise McLellan about his biggest takeaways from the two-day event.

At Reuters Pharma USA last week in Philadelphia, both drug pricing and the Inflatino Reduction Act were hot topics, so editor-in-chief Jonah Comstock caught up with Mindy McGrath, senior executive and health industry advisor at Vynamic, an Inizio company, to get an overview of where things stand in 2024.

Get live coverage of the latest updates and developments from Day 2 of Reuters Pharma USA 2024. Stay informed with real-time news and insights from the event.

Get live coverage of the latest updates and developments from Day 1 of Reuters Pharma USA 2024. Stay informed with real-time news and insights from the event.

At Reuters Pharma USA, a who’s who of executives from major pharma companies will gather in Philadelphia to go in-depth on every part of the business, from marketing and market access to research and development, and to patient engagement.

Explore the latest trends reshaping clinical trials in an insightful interview with Dr. Iris Loew-Friedrich from UCB. Learn about the impact of data and diversity in shaping the future of clinical research.

On today’s podcast, host Jonah Comstock is joined by Meri Beckwith, co-founder of Lindus Health, a next-gen CRO that includes digital therapeutics among its specialties. They talk a little bit about the often unseen difficulties of validating a digital therapeutic through a clinical trial.

Stay updated with the latest pharma and biotech hires from February 2024 at companies like AbbVie, Astellas, EnteroBiotix, and Resalis Therapeutics in Changing Faces.